
Transactions: Healthcare
Filter


Rights issue in Biovitrum (SE) — SEK 1.5 billion

Directed new share issue in Oasmia Pharmaceutical AB (SE) — SEK 48 million

Acquisition of Lund Research Center (SE) by Active Biotech AB (SE) from Pharmacia & Upjohn (US) — SEK 380 million

Initial public offering and secondary offering of shares in Meda AB (SE) — SEK 155 million

New share issue in Axis Shield (UK/NO) — NOK 130 million

Secondary offering of shares in Lundbeck (DK) — DKK 1.7 billion

Redemption in Elekta AB (SE) — SEK 311.5 million

Rights issue in Medivir (SE) — SEK 225 million

Secondary placing of 1.7 million shares in Clavis Pharma ASA (NO) — NOK 84 million

Secondary placing of shares in William Demant Invest (DK) — DKK 1.3 billion
